nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—lung cancer—esophageal cancer	0.662	1	CtDrD
Vinorelbine—ABCB1—esophageal cancer	0.137	1	CbGaD
Vinorelbine—TUBB3—digestive system—esophageal cancer	0.00132	0.0489	CbGeAlD
Vinorelbine—TUBB3—lung—esophageal cancer	0.0011	0.0408	CbGeAlD
Vinorelbine—TUBB2B—bronchus—esophageal cancer	0.001	0.0372	CbGeAlD
Vinorelbine—Neurotoxicity—Capecitabine—esophageal cancer	0.000953	0.0101	CcSEcCtD
Vinorelbine—TUBB—bronchus—esophageal cancer	0.00095	0.0352	CbGeAlD
Vinorelbine—TUBB6—epithelium—esophageal cancer	0.000946	0.0351	CbGeAlD
Vinorelbine—TUBB2A—bronchus—esophageal cancer	0.000945	0.0351	CbGeAlD
Vinorelbine—TUBB6—bronchus—esophageal cancer	0.000932	0.0346	CbGeAlD
Vinorelbine—TUBB—smooth muscle tissue—esophageal cancer	0.00093	0.0345	CbGeAlD
Vinorelbine—TUBB2A—smooth muscle tissue—esophageal cancer	0.000925	0.0343	CbGeAlD
Vinorelbine—TUBB6—smooth muscle tissue—esophageal cancer	0.000912	0.0338	CbGeAlD
Vinorelbine—TUBB2B—trachea—esophageal cancer	0.000901	0.0334	CbGeAlD
Vinorelbine—Nephropathy toxic—Cisplatin—esophageal cancer	0.000873	0.00928	CcSEcCtD
Vinorelbine—Inappropriate antidiuretic hormone secretion—Cisplatin—esophageal cancer	0.000863	0.00917	CcSEcCtD
Vinorelbine—Ileus paralytic—Capecitabine—esophageal cancer	0.000855	0.00908	CcSEcCtD
Vinorelbine—TUBB—trachea—esophageal cancer	0.000853	0.0316	CbGeAlD
Vinorelbine—TUBB2A—trachea—esophageal cancer	0.000849	0.0315	CbGeAlD
Vinorelbine—TUBB6—trachea—esophageal cancer	0.000837	0.031	CbGeAlD
Vinorelbine—Febrile neutropenia—Cisplatin—esophageal cancer	0.000834	0.00886	CcSEcCtD
Vinorelbine—TUBB4B—bronchus—esophageal cancer	0.00081	0.0301	CbGeAlD
Vinorelbine—TUBB4A—digestive system—esophageal cancer	0.000802	0.0298	CbGeAlD
Vinorelbine—TUBB4B—smooth muscle tissue—esophageal cancer	0.000793	0.0294	CbGeAlD
Vinorelbine—Skin necrosis—Methotrexate—esophageal cancer	0.000788	0.00837	CcSEcCtD
Vinorelbine—Peripheral coldness—Capecitabine—esophageal cancer	0.000776	0.00825	CcSEcCtD
Vinorelbine—TUBB2B—digestive system—esophageal cancer	0.000776	0.0288	CbGeAlD
Vinorelbine—Paresis—Methotrexate—esophageal cancer	0.000754	0.00801	CcSEcCtD
Vinorelbine—TUBB2A—digestive system—esophageal cancer	0.00073	0.0271	CbGeAlD
Vinorelbine—TUBB4B—trachea—esophageal cancer	0.000728	0.027	CbGeAlD
Vinorelbine—TUBB6—digestive system—esophageal cancer	0.00072	0.0267	CbGeAlD
Vinorelbine—Neurotoxicity—Methotrexate—esophageal cancer	0.00071	0.00754	CcSEcCtD
Vinorelbine—Voacamine—ABCB1—esophageal cancer	0.000696	0.275	CrCbGaD
Vinorelbine—Vinblastine—ABCC2—esophageal cancer	0.000675	0.267	CrCbGaD
Vinorelbine—TUBB4A—lung—esophageal cancer	0.00067	0.0249	CbGeAlD
Vinorelbine—Mucosal inflammation—Capecitabine—esophageal cancer	0.000668	0.00709	CcSEcCtD
Vinorelbine—Vincristine—ABCC2—esophageal cancer	0.000664	0.263	CrCbGaD
Vinorelbine—TUBB2B—lung—esophageal cancer	0.000648	0.024	CbGeAlD
Vinorelbine—Necrosis—Cisplatin—esophageal cancer	0.000639	0.00679	CcSEcCtD
Vinorelbine—TUBB4B—digestive system—esophageal cancer	0.000626	0.0232	CbGeAlD
Vinorelbine—Febrile neutropenia—Capecitabine—esophageal cancer	0.000614	0.00653	CcSEcCtD
Vinorelbine—TUBB—lung—esophageal cancer	0.000613	0.0227	CbGeAlD
Vinorelbine—TUBB2A—lung—esophageal cancer	0.00061	0.0226	CbGeAlD
Vinorelbine—Deep vein thrombosis—Capecitabine—esophageal cancer	0.000608	0.00646	CcSEcCtD
Vinorelbine—Infection—Carboplatin—esophageal cancer	0.000606	0.00644	CcSEcCtD
Vinorelbine—TUBB6—lung—esophageal cancer	0.000601	0.0223	CbGeAlD
Vinorelbine—Bacterial infection—Methotrexate—esophageal cancer	0.000596	0.00633	CcSEcCtD
Vinorelbine—Embolism—Capecitabine—esophageal cancer	0.000576	0.00612	CcSEcCtD
Vinorelbine—Extravasation—Cisplatin—esophageal cancer	0.000575	0.00611	CcSEcCtD
Vinorelbine—Bone marrow depression—Capecitabine—esophageal cancer	0.000548	0.00582	CcSEcCtD
Vinorelbine—Intestinal obstruction—Capecitabine—esophageal cancer	0.000542	0.00576	CcSEcCtD
Vinorelbine—Hearing impaired—Cisplatin—esophageal cancer	0.000527	0.0056	CcSEcCtD
Vinorelbine—TUBB4B—lung—esophageal cancer	0.000523	0.0194	CbGeAlD
Vinorelbine—Ileus—Capecitabine—esophageal cancer	0.000522	0.00555	CcSEcCtD
Vinorelbine—Thrombosis—Capecitabine—esophageal cancer	0.000522	0.00555	CcSEcCtD
Vinorelbine—Pain—Carboplatin—esophageal cancer	0.000522	0.00554	CcSEcCtD
Vinorelbine—Blister—Capecitabine—esophageal cancer	0.000513	0.00545	CcSEcCtD
Vinorelbine—Mucosal inflammation—Methotrexate—esophageal cancer	0.000497	0.00528	CcSEcCtD
Vinorelbine—Body temperature increased—Carboplatin—esophageal cancer	0.000482	0.00512	CcSEcCtD
Vinorelbine—Skin exfoliation—Cisplatin—esophageal cancer	0.000479	0.00509	CcSEcCtD
Vinorelbine—Hyperaesthesia—Capecitabine—esophageal cancer	0.000471	0.005	CcSEcCtD
Vinorelbine—Myocardial ischaemia—Capecitabine—esophageal cancer	0.00046	0.00489	CcSEcCtD
Vinorelbine—TUBB4A—lymph node—esophageal cancer	0.000458	0.017	CbGeAlD
Vinorelbine—Febrile neutropenia—Methotrexate—esophageal cancer	0.000457	0.00486	CcSEcCtD
Vinorelbine—Injection site pain—Capecitabine—esophageal cancer	0.000453	0.00481	CcSEcCtD
Vinorelbine—Deep vein thrombosis—Methotrexate—esophageal cancer	0.000452	0.00481	CcSEcCtD
Vinorelbine—TUBB2B—lymph node—esophageal cancer	0.000443	0.0164	CbGeAlD
Vinorelbine—Hypoxia—Methotrexate—esophageal cancer	0.000433	0.0046	CcSEcCtD
Vinorelbine—Embolism—Methotrexate—esophageal cancer	0.000429	0.00455	CcSEcCtD
Vinorelbine—Phlebitis—Cisplatin—esophageal cancer	0.000423	0.00449	CcSEcCtD
Vinorelbine—TUBB—lymph node—esophageal cancer	0.000419	0.0155	CbGeAlD
Vinorelbine—TUBB2A—lymph node—esophageal cancer	0.000417	0.0155	CbGeAlD
Vinorelbine—Polyuria—Cisplatin—esophageal cancer	0.000415	0.0044	CcSEcCtD
Vinorelbine—TUBB6—lymph node—esophageal cancer	0.000411	0.0153	CbGeAlD
Vinorelbine—Bone marrow depression—Methotrexate—esophageal cancer	0.000408	0.00433	CcSEcCtD
Vinorelbine—Deafness—Cisplatin—esophageal cancer	0.000407	0.00432	CcSEcCtD
Vinorelbine—Blood bilirubin increased—Capecitabine—esophageal cancer	0.000391	0.00415	CcSEcCtD
Vinorelbine—Lung disorder—Methotrexate—esophageal cancer	0.000389	0.00413	CcSEcCtD
Vinorelbine—Hearing impaired—Capecitabine—esophageal cancer	0.000388	0.00413	CcSEcCtD
Vinorelbine—Gait disturbance—Capecitabine—esophageal cancer	0.000379	0.00402	CcSEcCtD
Vinorelbine—Cerebrovascular accident—Cisplatin—esophageal cancer	0.000371	0.00395	CcSEcCtD
Vinorelbine—Pulmonary embolism—Capecitabine—esophageal cancer	0.00037	0.00393	CcSEcCtD
Vinorelbine—Injection site reaction—Capecitabine—esophageal cancer	0.000367	0.0039	CcSEcCtD
Vinorelbine—Hyponatraemia—Cisplatin—esophageal cancer	0.000365	0.00388	CcSEcCtD
Vinorelbine—TUBB4B—lymph node—esophageal cancer	0.000358	0.0133	CbGeAlD
Vinorelbine—Skin exfoliation—Capecitabine—esophageal cancer	0.000353	0.00375	CcSEcCtD
Vinorelbine—Necrosis—Methotrexate—esophageal cancer	0.000351	0.00373	CcSEcCtD
Vinorelbine—Blood creatinine increased—Cisplatin—esophageal cancer	0.000341	0.00362	CcSEcCtD
Vinorelbine—Oesophagitis—Capecitabine—esophageal cancer	0.000338	0.00359	CcSEcCtD
Vinorelbine—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.000328	0.00348	CcSEcCtD
Vinorelbine—Sepsis—Capecitabine—esophageal cancer	0.000321	0.00341	CcSEcCtD
Vinorelbine—Extravasation—Methotrexate—esophageal cancer	0.000315	0.00335	CcSEcCtD
Vinorelbine—Phlebitis—Capecitabine—esophageal cancer	0.000311	0.00331	CcSEcCtD
Vinorelbine—Thrombophlebitis—Capecitabine—esophageal cancer	0.00031	0.00329	CcSEcCtD
Vinorelbine—Pancreatitis—Cisplatin—esophageal cancer	0.000308	0.00328	CcSEcCtD
Vinorelbine—Polyuria—Capecitabine—esophageal cancer	0.000306	0.00325	CcSEcCtD
Vinorelbine—Deafness—Capecitabine—esophageal cancer	0.0003	0.00319	CcSEcCtD
Vinorelbine—Pancytopenia—Cisplatin—esophageal cancer	0.000299	0.00317	CcSEcCtD
Vinorelbine—Hepatic failure—Capecitabine—esophageal cancer	0.000299	0.00317	CcSEcCtD
Vinorelbine—Dermatitis bullous—Capecitabine—esophageal cancer	0.000281	0.00298	CcSEcCtD
Vinorelbine—Respiratory failure—Methotrexate—esophageal cancer	0.00028	0.00298	CcSEcCtD
Vinorelbine—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000277	0.00294	CcSEcCtD
Vinorelbine—Pulmonary embolism—Methotrexate—esophageal cancer	0.000275	0.00292	CcSEcCtD
Vinorelbine—Myocardial infarction—Cisplatin—esophageal cancer	0.000275	0.00292	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000275	0.00292	CcSEcCtD
Vinorelbine—Cardiac failure—Capecitabine—esophageal cancer	0.000275	0.00292	CcSEcCtD
Vinorelbine—Lethargy—Capecitabine—esophageal cancer	0.000274	0.00291	CcSEcCtD
Vinorelbine—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000274	0.00291	CcSEcCtD
Vinorelbine—Stomatitis—Cisplatin—esophageal cancer	0.000273	0.00291	CcSEcCtD
Vinorelbine—Hyponatraemia—Capecitabine—esophageal cancer	0.000269	0.00286	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000265	0.00282	CcSEcCtD
Vinorelbine—Skin exfoliation—Methotrexate—esophageal cancer	0.000263	0.00279	CcSEcCtD
Vinorelbine—Aplastic anaemia—Methotrexate—esophageal cancer	0.000258	0.00275	CcSEcCtD
Vinorelbine—CYP3A4—digestive system—esophageal cancer	0.000257	0.00954	CbGeAlD
Vinorelbine—CYP2D6—digestive system—esophageal cancer	0.000253	0.00939	CbGeAlD
Vinorelbine—Blood creatinine increased—Capecitabine—esophageal cancer	0.000251	0.00267	CcSEcCtD
Vinorelbine—Vinblastine—ABCB1—esophageal cancer	0.000248	0.0983	CrCbGaD
Vinorelbine—Connective tissue disorder—Cisplatin—esophageal cancer	0.000247	0.00263	CcSEcCtD
Vinorelbine—Pulmonary oedema—Methotrexate—esophageal cancer	0.000245	0.0026	CcSEcCtD
Vinorelbine—Vincristine—ABCB1—esophageal cancer	0.000244	0.0966	CrCbGaD
Vinorelbine—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000242	0.00257	CcSEcCtD
Vinorelbine—ABCB1—epithelium—esophageal cancer	0.000239	0.00887	CbGeAlD
Vinorelbine—Sepsis—Methotrexate—esophageal cancer	0.000239	0.00254	CcSEcCtD
Vinorelbine—Muscular weakness—Capecitabine—esophageal cancer	0.000237	0.00251	CcSEcCtD
Vinorelbine—Flushing—Cisplatin—esophageal cancer	0.000234	0.00248	CcSEcCtD
Vinorelbine—Cardiac disorder—Cisplatin—esophageal cancer	0.000234	0.00248	CcSEcCtD
Vinorelbine—Dysphagia—Capecitabine—esophageal cancer	0.000232	0.00246	CcSEcCtD
Vinorelbine—Thrombophlebitis—Methotrexate—esophageal cancer	0.000231	0.00245	CcSEcCtD
Vinorelbine—Bronchospasm—Capecitabine—esophageal cancer	0.000228	0.00242	CcSEcCtD
Vinorelbine—Polyuria—Methotrexate—esophageal cancer	0.000227	0.00242	CcSEcCtD
Vinorelbine—Immune system disorder—Cisplatin—esophageal cancer	0.000227	0.00242	CcSEcCtD
Vinorelbine—Mediastinal disorder—Cisplatin—esophageal cancer	0.000227	0.00241	CcSEcCtD
Vinorelbine—Angina pectoris—Capecitabine—esophageal cancer	0.000226	0.0024	CcSEcCtD
Vinorelbine—Arrhythmia—Cisplatin—esophageal cancer	0.000225	0.00239	CcSEcCtD
Vinorelbine—Alopecia—Cisplatin—esophageal cancer	0.000223	0.00236	CcSEcCtD
Vinorelbine—Hepatic failure—Methotrexate—esophageal cancer	0.000222	0.00236	CcSEcCtD
Vinorelbine—Pancytopenia—Capecitabine—esophageal cancer	0.00022	0.00234	CcSEcCtD
Vinorelbine—Malnutrition—Cisplatin—esophageal cancer	0.000219	0.00233	CcSEcCtD
Vinorelbine—Erythema—Cisplatin—esophageal cancer	0.000219	0.00233	CcSEcCtD
Vinorelbine—Neutropenia—Capecitabine—esophageal cancer	0.000217	0.0023	CcSEcCtD
Vinorelbine—ABCB1—trachea—esophageal cancer	0.000212	0.00785	CbGeAlD
Vinorelbine—Weight decreased—Capecitabine—esophageal cancer	0.00021	0.00223	CcSEcCtD
Vinorelbine—Pneumonia—Capecitabine—esophageal cancer	0.000208	0.00221	CcSEcCtD
Vinorelbine—Infestation—Capecitabine—esophageal cancer	0.000207	0.0022	CcSEcCtD
Vinorelbine—Infestation NOS—Capecitabine—esophageal cancer	0.000207	0.0022	CcSEcCtD
Vinorelbine—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000204	0.00217	CcSEcCtD
Vinorelbine—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000204	0.00217	CcSEcCtD
Vinorelbine—Lethargy—Methotrexate—esophageal cancer	0.000204	0.00217	CcSEcCtD
Vinorelbine—Ill-defined disorder—Cisplatin—esophageal cancer	0.000203	0.00216	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000203	0.00215	CcSEcCtD
Vinorelbine—Myocardial infarction—Capecitabine—esophageal cancer	0.000203	0.00215	CcSEcCtD
Vinorelbine—Anaemia—Cisplatin—esophageal cancer	0.000203	0.00215	CcSEcCtD
Vinorelbine—Stomatitis—Capecitabine—esophageal cancer	0.000202	0.00214	CcSEcCtD
Vinorelbine—Malaise—Cisplatin—esophageal cancer	0.000198	0.0021	CcSEcCtD
Vinorelbine—Leukopenia—Cisplatin—esophageal cancer	0.000196	0.00208	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000196	0.00208	CcSEcCtD
Vinorelbine—Agranulocytosis—Capecitabine—esophageal cancer	0.000193	0.00205	CcSEcCtD
Vinorelbine—Myalgia—Cisplatin—esophageal cancer	0.000187	0.00198	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000185	0.00197	CcSEcCtD
Vinorelbine—Hypoaesthesia—Capecitabine—esophageal cancer	0.000185	0.00196	CcSEcCtD
Vinorelbine—Discomfort—Cisplatin—esophageal cancer	0.000184	0.00196	CcSEcCtD
Vinorelbine—Connective tissue disorder—Capecitabine—esophageal cancer	0.000182	0.00194	CcSEcCtD
Vinorelbine—ABCB1—digestive system—esophageal cancer	0.000182	0.00675	CbGeAlD
Vinorelbine—Anaphylactic shock—Cisplatin—esophageal cancer	0.000179	0.0019	CcSEcCtD
Vinorelbine—Infection—Cisplatin—esophageal cancer	0.000178	0.00189	CcSEcCtD
Vinorelbine—Nervous system disorder—Cisplatin—esophageal cancer	0.000175	0.00186	CcSEcCtD
Vinorelbine—Thrombocytopenia—Cisplatin—esophageal cancer	0.000175	0.00186	CcSEcCtD
Vinorelbine—Tachycardia—Cisplatin—esophageal cancer	0.000175	0.00186	CcSEcCtD
Vinorelbine—Skin disorder—Cisplatin—esophageal cancer	0.000174	0.00185	CcSEcCtD
Vinorelbine—Flushing—Capecitabine—esophageal cancer	0.000172	0.00183	CcSEcCtD
Vinorelbine—Cardiac disorder—Capecitabine—esophageal cancer	0.000172	0.00183	CcSEcCtD
Vinorelbine—Anorexia—Cisplatin—esophageal cancer	0.000171	0.00181	CcSEcCtD
Vinorelbine—Pancreatitis—Methotrexate—esophageal cancer	0.000169	0.0018	CcSEcCtD
Vinorelbine—Angiopathy—Capecitabine—esophageal cancer	0.000168	0.00179	CcSEcCtD
Vinorelbine—Immune system disorder—Capecitabine—esophageal cancer	0.000168	0.00178	CcSEcCtD
Vinorelbine—Mediastinal disorder—Capecitabine—esophageal cancer	0.000167	0.00178	CcSEcCtD
Vinorelbine—Hypotension—Cisplatin—esophageal cancer	0.000167	0.00178	CcSEcCtD
Vinorelbine—Arrhythmia—Capecitabine—esophageal cancer	0.000166	0.00176	CcSEcCtD
Vinorelbine—Alopecia—Capecitabine—esophageal cancer	0.000164	0.00174	CcSEcCtD
Vinorelbine—Pancytopenia—Methotrexate—esophageal cancer	0.000164	0.00174	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000163	0.00173	CcSEcCtD
Vinorelbine—Malnutrition—Capecitabine—esophageal cancer	0.000162	0.00172	CcSEcCtD
Vinorelbine—Erythema—Capecitabine—esophageal cancer	0.000162	0.00172	CcSEcCtD
Vinorelbine—Neutropenia—Methotrexate—esophageal cancer	0.000161	0.00172	CcSEcCtD
Vinorelbine—Paraesthesia—Cisplatin—esophageal cancer	0.000161	0.00171	CcSEcCtD
Vinorelbine—Dyspnoea—Cisplatin—esophageal cancer	0.000159	0.00169	CcSEcCtD
Vinorelbine—Back pain—Capecitabine—esophageal cancer	0.000156	0.00166	CcSEcCtD
Vinorelbine—Decreased appetite—Cisplatin—esophageal cancer	0.000156	0.00165	CcSEcCtD
Vinorelbine—Pneumonia—Methotrexate—esophageal cancer	0.000155	0.00165	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000154	0.00164	CcSEcCtD
Vinorelbine—Infestation NOS—Methotrexate—esophageal cancer	0.000154	0.00164	CcSEcCtD
Vinorelbine—Infestation—Methotrexate—esophageal cancer	0.000154	0.00164	CcSEcCtD
Vinorelbine—Pain—Cisplatin—esophageal cancer	0.000153	0.00163	CcSEcCtD
Vinorelbine—ABCB1—lung—esophageal cancer	0.000152	0.00564	CbGeAlD
Vinorelbine—Stomatitis—Methotrexate—esophageal cancer	0.00015	0.00159	CcSEcCtD
Vinorelbine—Ill-defined disorder—Capecitabine—esophageal cancer	0.00015	0.00159	CcSEcCtD
Vinorelbine—Anaemia—Capecitabine—esophageal cancer	0.000149	0.00159	CcSEcCtD
Vinorelbine—Feeling abnormal—Cisplatin—esophageal cancer	0.000147	0.00157	CcSEcCtD
Vinorelbine—Malaise—Capecitabine—esophageal cancer	0.000146	0.00155	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000146	0.00155	CcSEcCtD
Vinorelbine—Vertigo—Capecitabine—esophageal cancer	0.000145	0.00154	CcSEcCtD
Vinorelbine—Leukopenia—Capecitabine—esophageal cancer	0.000145	0.00154	CcSEcCtD
Vinorelbine—Agranulocytosis—Methotrexate—esophageal cancer	0.000144	0.00153	CcSEcCtD
Vinorelbine—Palpitations—Capecitabine—esophageal cancer	0.000143	0.00152	CcSEcCtD
Vinorelbine—Body temperature increased—Cisplatin—esophageal cancer	0.000141	0.0015	CcSEcCtD
Vinorelbine—Cough—Capecitabine—esophageal cancer	0.000141	0.0015	CcSEcCtD
Vinorelbine—Hypertension—Capecitabine—esophageal cancer	0.00014	0.00148	CcSEcCtD
Vinorelbine—Arthralgia—Capecitabine—esophageal cancer	0.000138	0.00146	CcSEcCtD
Vinorelbine—Chest pain—Capecitabine—esophageal cancer	0.000138	0.00146	CcSEcCtD
Vinorelbine—Myalgia—Capecitabine—esophageal cancer	0.000138	0.00146	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000137	0.00145	CcSEcCtD
Vinorelbine—Discomfort—Capecitabine—esophageal cancer	0.000136	0.00144	CcSEcCtD
Vinorelbine—Hypersensitivity—Cisplatin—esophageal cancer	0.000132	0.0014	CcSEcCtD
Vinorelbine—Infection—Capecitabine—esophageal cancer	0.000131	0.00139	CcSEcCtD
Vinorelbine—Nervous system disorder—Capecitabine—esophageal cancer	0.000129	0.00137	CcSEcCtD
Vinorelbine—Thrombocytopenia—Capecitabine—esophageal cancer	0.000129	0.00137	CcSEcCtD
Vinorelbine—Tachycardia—Capecitabine—esophageal cancer	0.000129	0.00137	CcSEcCtD
Vinorelbine—Asthenia—Cisplatin—esophageal cancer	0.000128	0.00136	CcSEcCtD
Vinorelbine—Cardiac disorder—Methotrexate—esophageal cancer	0.000128	0.00136	CcSEcCtD
Vinorelbine—Skin disorder—Capecitabine—esophageal cancer	0.000128	0.00136	CcSEcCtD
Vinorelbine—Anorexia—Capecitabine—esophageal cancer	0.000126	0.00134	CcSEcCtD
Vinorelbine—Angiopathy—Methotrexate—esophageal cancer	0.000125	0.00133	CcSEcCtD
Vinorelbine—Immune system disorder—Methotrexate—esophageal cancer	0.000125	0.00133	CcSEcCtD
Vinorelbine—Mediastinal disorder—Methotrexate—esophageal cancer	0.000125	0.00132	CcSEcCtD
Vinorelbine—Hypotension—Capecitabine—esophageal cancer	0.000123	0.00131	CcSEcCtD
Vinorelbine—Diarrhoea—Cisplatin—esophageal cancer	0.000122	0.0013	CcSEcCtD
Vinorelbine—Alopecia—Methotrexate—esophageal cancer	0.000122	0.0013	CcSEcCtD
Vinorelbine—Erythema—Methotrexate—esophageal cancer	0.00012	0.00128	CcSEcCtD
Vinorelbine—Malnutrition—Methotrexate—esophageal cancer	0.00012	0.00128	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00012	0.00128	CcSEcCtD
Vinorelbine—Paraesthesia—Capecitabine—esophageal cancer	0.000118	0.00126	CcSEcCtD
Vinorelbine—Dyspnoea—Capecitabine—esophageal cancer	0.000118	0.00125	CcSEcCtD
Vinorelbine—Back pain—Methotrexate—esophageal cancer	0.000116	0.00124	CcSEcCtD
Vinorelbine—Decreased appetite—Capecitabine—esophageal cancer	0.000115	0.00122	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000114	0.00121	CcSEcCtD
Vinorelbine—Vomiting—Cisplatin—esophageal cancer	0.000114	0.00121	CcSEcCtD
Vinorelbine—Fatigue—Capecitabine—esophageal cancer	0.000114	0.00121	CcSEcCtD
Vinorelbine—Rash—Cisplatin—esophageal cancer	0.000113	0.0012	CcSEcCtD
Vinorelbine—Constipation—Capecitabine—esophageal cancer	0.000113	0.0012	CcSEcCtD
Vinorelbine—Pain—Capecitabine—esophageal cancer	0.000113	0.0012	CcSEcCtD
Vinorelbine—Dermatitis—Cisplatin—esophageal cancer	0.000113	0.0012	CcSEcCtD
Vinorelbine—Ill-defined disorder—Methotrexate—esophageal cancer	0.000112	0.00119	CcSEcCtD
Vinorelbine—Anaemia—Methotrexate—esophageal cancer	0.000111	0.00118	CcSEcCtD
Vinorelbine—Feeling abnormal—Capecitabine—esophageal cancer	0.000109	0.00115	CcSEcCtD
Vinorelbine—Malaise—Methotrexate—esophageal cancer	0.000108	0.00115	CcSEcCtD
Vinorelbine—Vertigo—Methotrexate—esophageal cancer	0.000108	0.00115	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000108	0.00115	CcSEcCtD
Vinorelbine—Leukopenia—Methotrexate—esophageal cancer	0.000108	0.00114	CcSEcCtD
Vinorelbine—Nausea—Cisplatin—esophageal cancer	0.000106	0.00113	CcSEcCtD
Vinorelbine—Cough—Methotrexate—esophageal cancer	0.000105	0.00112	CcSEcCtD
Vinorelbine—Urticaria—Capecitabine—esophageal cancer	0.000105	0.00111	CcSEcCtD
Vinorelbine—Abdominal pain—Capecitabine—esophageal cancer	0.000104	0.00111	CcSEcCtD
Vinorelbine—Body temperature increased—Capecitabine—esophageal cancer	0.000104	0.00111	CcSEcCtD
Vinorelbine—ABCB1—lymph node—esophageal cancer	0.000104	0.00386	CbGeAlD
Vinorelbine—Chest pain—Methotrexate—esophageal cancer	0.000102	0.00109	CcSEcCtD
Vinorelbine—Arthralgia—Methotrexate—esophageal cancer	0.000102	0.00109	CcSEcCtD
Vinorelbine—Myalgia—Methotrexate—esophageal cancer	0.000102	0.00109	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000102	0.00108	CcSEcCtD
Vinorelbine—Discomfort—Methotrexate—esophageal cancer	0.000101	0.00108	CcSEcCtD
Vinorelbine—Anaphylactic shock—Methotrexate—esophageal cancer	9.82e-05	0.00104	CcSEcCtD
Vinorelbine—Infection—Methotrexate—esophageal cancer	9.75e-05	0.00104	CcSEcCtD
Vinorelbine—Hypersensitivity—Capecitabine—esophageal cancer	9.72e-05	0.00103	CcSEcCtD
Vinorelbine—Nervous system disorder—Methotrexate—esophageal cancer	9.63e-05	0.00102	CcSEcCtD
Vinorelbine—Thrombocytopenia—Methotrexate—esophageal cancer	9.61e-05	0.00102	CcSEcCtD
Vinorelbine—Skin disorder—Methotrexate—esophageal cancer	9.54e-05	0.00101	CcSEcCtD
Vinorelbine—Asthenia—Capecitabine—esophageal cancer	9.46e-05	0.00101	CcSEcCtD
Vinorelbine—Anorexia—Methotrexate—esophageal cancer	9.36e-05	0.000994	CcSEcCtD
Vinorelbine—Pruritus—Capecitabine—esophageal cancer	9.33e-05	0.000991	CcSEcCtD
Vinorelbine—Hypotension—Methotrexate—esophageal cancer	9.17e-05	0.000975	CcSEcCtD
Vinorelbine—Diarrhoea—Capecitabine—esophageal cancer	9.02e-05	0.000959	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	8.94e-05	0.00095	CcSEcCtD
Vinorelbine—Paraesthesia—Methotrexate—esophageal cancer	8.82e-05	0.000937	CcSEcCtD
Vinorelbine—Dyspnoea—Methotrexate—esophageal cancer	8.75e-05	0.00093	CcSEcCtD
Vinorelbine—Dizziness—Capecitabine—esophageal cancer	8.72e-05	0.000927	CcSEcCtD
Vinorelbine—Decreased appetite—Methotrexate—esophageal cancer	8.53e-05	0.000907	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Methotrexate—esophageal cancer	8.48e-05	0.000901	CcSEcCtD
Vinorelbine—Fatigue—Methotrexate—esophageal cancer	8.46e-05	0.000899	CcSEcCtD
Vinorelbine—Pain—Methotrexate—esophageal cancer	8.4e-05	0.000892	CcSEcCtD
Vinorelbine—Vomiting—Capecitabine—esophageal cancer	8.38e-05	0.000891	CcSEcCtD
Vinorelbine—Rash—Capecitabine—esophageal cancer	8.32e-05	0.000884	CcSEcCtD
Vinorelbine—Dermatitis—Capecitabine—esophageal cancer	8.31e-05	0.000883	CcSEcCtD
Vinorelbine—Headache—Capecitabine—esophageal cancer	8.26e-05	0.000878	CcSEcCtD
Vinorelbine—Feeling abnormal—Methotrexate—esophageal cancer	8.09e-05	0.00086	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Methotrexate—esophageal cancer	8.03e-05	0.000853	CcSEcCtD
Vinorelbine—Nausea—Capecitabine—esophageal cancer	7.83e-05	0.000832	CcSEcCtD
Vinorelbine—Urticaria—Methotrexate—esophageal cancer	7.8e-05	0.000829	CcSEcCtD
Vinorelbine—Body temperature increased—Methotrexate—esophageal cancer	7.76e-05	0.000825	CcSEcCtD
Vinorelbine—Abdominal pain—Methotrexate—esophageal cancer	7.76e-05	0.000825	CcSEcCtD
Vinorelbine—Hypersensitivity—Methotrexate—esophageal cancer	7.23e-05	0.000769	CcSEcCtD
Vinorelbine—Asthenia—Methotrexate—esophageal cancer	7.04e-05	0.000748	CcSEcCtD
Vinorelbine—Pruritus—Methotrexate—esophageal cancer	6.95e-05	0.000738	CcSEcCtD
Vinorelbine—Diarrhoea—Methotrexate—esophageal cancer	6.72e-05	0.000714	CcSEcCtD
Vinorelbine—Dizziness—Methotrexate—esophageal cancer	6.49e-05	0.00069	CcSEcCtD
Vinorelbine—Vomiting—Methotrexate—esophageal cancer	6.24e-05	0.000663	CcSEcCtD
Vinorelbine—Rash—Methotrexate—esophageal cancer	6.19e-05	0.000658	CcSEcCtD
Vinorelbine—Dermatitis—Methotrexate—esophageal cancer	6.18e-05	0.000657	CcSEcCtD
Vinorelbine—Headache—Methotrexate—esophageal cancer	6.15e-05	0.000653	CcSEcCtD
Vinorelbine—Nausea—Methotrexate—esophageal cancer	5.83e-05	0.00062	CcSEcCtD
Vinorelbine—TUBB3—Metabolism of proteins—GHRL—esophageal cancer	4.99e-05	0.000644	CbGpPWpGaD
Vinorelbine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	4.97e-05	0.000642	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—HSPA5—esophageal cancer	4.96e-05	0.000641	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—GSTO1—esophageal cancer	4.95e-05	0.00064	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—PSME2—esophageal cancer	4.93e-05	0.000637	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—PSME1—esophageal cancer	4.93e-05	0.000637	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—ACTB—esophageal cancer	4.92e-05	0.000636	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—CALR—esophageal cancer	4.91e-05	0.000635	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—BUB1B—esophageal cancer	4.91e-05	0.000634	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—FBXW7—esophageal cancer	4.9e-05	0.000634	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—GSTO1—esophageal cancer	4.89e-05	0.000631	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—GHRL—esophageal cancer	4.83e-05	0.000624	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—CALR—esophageal cancer	4.8e-05	0.000621	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—FBXW7—esophageal cancer	4.75e-05	0.000614	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—GHRL—esophageal cancer	4.72e-05	0.00061	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—esophageal cancer	4.71e-05	0.000608	CbGpPWpGaD
Vinorelbine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	4.67e-05	0.000604	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CHEK2—esophageal cancer	4.67e-05	0.000603	CbGpPWpGaD
Vinorelbine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	4.65e-05	0.0006	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—FBXW7—esophageal cancer	4.64e-05	0.0006	CbGpPWpGaD
Vinorelbine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	4.59e-05	0.000593	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—ACTB—esophageal cancer	4.5e-05	0.000582	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—BUB1B—esophageal cancer	4.49e-05	0.00058	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.46e-05	0.000576	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.46e-05	0.000576	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—HSPA5—esophageal cancer	4.45e-05	0.000575	CbGpPWpGaD
Vinorelbine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	4.43e-05	0.000572	CbGpPWpGaD
Vinorelbine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	4.37e-05	0.000565	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—CALR—esophageal cancer	4.31e-05	0.000557	CbGpPWpGaD
Vinorelbine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	4.31e-05	0.000557	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.31e-05	0.000556	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—NOS2—esophageal cancer	4.28e-05	0.000554	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	4.28e-05	0.000553	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—ABCB1—esophageal cancer	4.28e-05	0.000553	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—ADH7—esophageal cancer	4.27e-05	0.000552	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CHEK2—esophageal cancer	4.27e-05	0.000552	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—GHRL—esophageal cancer	4.24e-05	0.000548	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—FBXW7—esophageal cancer	4.17e-05	0.000539	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.17e-05	0.000539	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	4.13e-05	0.000534	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.08e-05	0.000527	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—HSPA5—esophageal cancer	4.07e-05	0.000526	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—ALDH2—esophageal cancer	4.04e-05	0.000522	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—ABCB1—esophageal cancer	4e-05	0.000517	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—CALR—esophageal cancer	3.94e-05	0.00051	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.91e-05	0.000506	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—GHRL—esophageal cancer	3.88e-05	0.000501	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—CREBBP—esophageal cancer	3.85e-05	0.000497	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—GSTT1—esophageal cancer	3.84e-05	0.000496	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—FBXW7—esophageal cancer	3.81e-05	0.000493	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—CYP2A6—esophageal cancer	3.8e-05	0.000491	CbGpPWpGaD
Vinorelbine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	3.77e-05	0.000487	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	3.75e-05	0.000484	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.66e-05	0.000473	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—PTGS1—esophageal cancer	3.6e-05	0.000465	CbGpPWpGaD
Vinorelbine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	3.54e-05	0.000458	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.51e-05	0.000454	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	3.48e-05	0.00045	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	3.44e-05	0.000445	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—RB1—esophageal cancer	3.44e-05	0.000445	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	3.44e-05	0.000444	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.35e-05	0.000433	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—CASP8—esophageal cancer	3.35e-05	0.000432	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	3.24e-05	0.000419	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.21e-05	0.000415	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	3.19e-05	0.000413	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	3.15e-05	0.000407	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—RB1—esophageal cancer	3.08e-05	0.000398	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—CYP1B1—esophageal cancer	3.06e-05	0.000395	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	3.03e-05	0.000391	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—CYP1B1—esophageal cancer	3.02e-05	0.00039	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	3e-05	0.000387	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	2.98e-05	0.000385	CbGpPWpGaD
Vinorelbine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—esophageal cancer	2.9e-05	0.000374	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—CYP19A1—esophageal cancer	2.88e-05	0.000372	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.86e-05	0.00037	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.86e-05	0.00037	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—RB1—esophageal cancer	2.85e-05	0.000369	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—CYP19A1—esophageal cancer	2.84e-05	0.000367	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	2.8e-05	0.000362	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.76e-05	0.000357	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CDKN2A—esophageal cancer	2.71e-05	0.00035	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.67e-05	0.000346	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	2.65e-05	0.000343	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	2.64e-05	0.000341	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—EP300—esophageal cancer	2.62e-05	0.000338	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.62e-05	0.000338	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—RB1—esophageal cancer	2.61e-05	0.000337	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CCND1—esophageal cancer	2.56e-05	0.00033	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—RB1—esophageal cancer	2.55e-05	0.00033	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	2.54e-05	0.000328	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	2.53e-05	0.000327	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	2.51e-05	0.000325	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	2.51e-05	0.000324	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	2.48e-05	0.000321	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	2.47e-05	0.00032	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	2.46e-05	0.000318	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	2.43e-05	0.000314	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	2.43e-05	0.000314	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	2.35e-05	0.000304	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—EP300—esophageal cancer	2.35e-05	0.000304	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.35e-05	0.000303	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—RB1—esophageal cancer	2.33e-05	0.000301	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	2.33e-05	0.000301	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	2.29e-05	0.000296	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CCND1—esophageal cancer	2.29e-05	0.000295	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDKN2A—esophageal cancer	2.24e-05	0.00029	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CDKN1A—esophageal cancer	2.21e-05	0.000286	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.15e-05	0.000278	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CCND1—esophageal cancer	2.12e-05	0.000274	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—EP300—esophageal cancer	2.1e-05	0.000272	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—MYC—esophageal cancer	2.05e-05	0.000265	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDKN2A—esophageal cancer	2.05e-05	0.000265	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	2.05e-05	0.000265	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	2e-05	0.000259	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	1.97e-05	0.000255	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—EP300—esophageal cancer	1.95e-05	0.000252	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CCND1—esophageal cancer	1.94e-05	0.00025	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CCND1—esophageal cancer	1.89e-05	0.000245	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	1.88e-05	0.000243	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	1.87e-05	0.000242	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	1.86e-05	0.00024	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	1.84e-05	0.000238	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—MYC—esophageal cancer	1.83e-05	0.000237	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDKN1A—esophageal cancer	1.83e-05	0.000237	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—EP300—esophageal cancer	1.78e-05	0.00023	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—EP300—esophageal cancer	1.74e-05	0.000225	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CCND1—esophageal cancer	1.73e-05	0.000224	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—MYC—esophageal cancer	1.7e-05	0.00022	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDKN1A—esophageal cancer	1.68e-05	0.000217	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	1.67e-05	0.000216	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	1.65e-05	0.000213	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	1.64e-05	0.000212	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SLC52A3—esophageal cancer	1.64e-05	0.000212	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—BLVRB—esophageal cancer	1.64e-05	0.000212	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—EP300—esophageal cancer	1.59e-05	0.000206	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—MYC—esophageal cancer	1.55e-05	0.000201	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—BLVRB—esophageal cancer	1.55e-05	0.0002	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SLC52A3—esophageal cancer	1.55e-05	0.0002	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—MYC—esophageal cancer	1.52e-05	0.000196	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—TP53—esophageal cancer	1.51e-05	0.000195	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	1.42e-05	0.000183	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CA1—esophageal cancer	1.4e-05	0.00018	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SLC10A2—esophageal cancer	1.4e-05	0.00018	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—MYC—esophageal cancer	1.39e-05	0.00018	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	1.38e-05	0.000178	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	1.35e-05	0.000174	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SLC10A2—esophageal cancer	1.31e-05	0.00017	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CA1—esophageal cancer	1.31e-05	0.00017	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CA2—esophageal cancer	1.28e-05	0.000165	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—TP53—esophageal cancer	1.25e-05	0.000161	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	1.22e-05	0.000157	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CA2—esophageal cancer	1.2e-05	0.000155	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PLCE1—esophageal cancer	1.19e-05	0.000153	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ADH7—esophageal cancer	1.19e-05	0.000153	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	1.18e-05	0.000152	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TP53—esophageal cancer	1.14e-05	0.000147	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	1.12e-05	0.000145	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PLCE1—esophageal cancer	1.12e-05	0.000144	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ADH7—esophageal cancer	1.12e-05	0.000144	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ADH1B—esophageal cancer	1.04e-05	0.000134	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.02e-05	0.000131	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—BLVRB—esophageal cancer	1.01e-05	0.000131	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	1.01e-05	0.000131	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—TYMP—esophageal cancer	9.94e-06	0.000128	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ADH1B—esophageal cancer	9.8e-06	0.000127	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	9.76e-06	0.000126	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP26A1—esophageal cancer	9.67e-06	0.000125	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	9.54e-06	0.000123	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ALOX15—esophageal cancer	9.42e-06	0.000122	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—TYMP—esophageal cancer	9.37e-06	0.000121	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP26A1—esophageal cancer	9.11e-06	0.000118	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—TPI1—esophageal cancer	8.99e-06	0.000116	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTO1—esophageal cancer	8.99e-06	0.000116	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ALOX15—esophageal cancer	8.88e-06	0.000115	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ALDOB—esophageal cancer	8.62e-06	0.000111	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CA1—esophageal cancer	8.6e-06	0.000111	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	8.6e-06	0.000111	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTO1—esophageal cancer	8.47e-06	0.000109	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—TPI1—esophageal cancer	8.47e-06	0.000109	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GAPDH—esophageal cancer	8.3e-06	0.000107	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	8.28e-06	0.000107	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CRABP1—esophageal cancer	8.22e-06	0.000106	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ALDOB—esophageal cancer	8.12e-06	0.000105	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	8.01e-06	0.000104	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CA2—esophageal cancer	7.86e-06	0.000102	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GNG7—esophageal cancer	7.82e-06	0.000101	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GAPDH—esophageal cancer	7.82e-06	0.000101	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CRABP1—esophageal cancer	7.75e-06	0.0001	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GNG7—esophageal cancer	7.37e-06	9.52e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ALDH2—esophageal cancer	7.33e-06	9.47e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ADH7—esophageal cancer	7.31e-06	9.44e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PLCE1—esophageal cancer	7.31e-06	9.44e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTT1—esophageal cancer	6.97e-06	9.01e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ALDH2—esophageal cancer	6.91e-06	8.92e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP2A6—esophageal cancer	6.89e-06	8.9e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTT1—esophageal cancer	6.57e-06	8.49e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ENO1—esophageal cancer	6.53e-06	8.44e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PTGS1—esophageal cancer	6.53e-06	8.44e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	6.53e-06	8.43e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP2A6—esophageal cancer	6.49e-06	8.39e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PSME2—esophageal cancer	6.44e-06	8.32e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PSME1—esophageal cancer	6.44e-06	8.32e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ADH1B—esophageal cancer	6.41e-06	8.28e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ENO1—esophageal cancer	6.16e-06	7.95e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PTGS1—esophageal cancer	6.16e-06	7.95e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—TYMP—esophageal cancer	6.12e-06	7.91e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PSME2—esophageal cancer	6.07e-06	7.84e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PSME1—esophageal cancer	6.07e-06	7.84e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	5.96e-06	7.7e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ALOX15—esophageal cancer	5.81e-06	7.5e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP1B1—esophageal cancer	5.55e-06	7.18e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—TPI1—esophageal cancer	5.54e-06	7.16e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTO1—esophageal cancer	5.54e-06	7.16e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ALDOB—esophageal cancer	5.31e-06	6.86e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	5.23e-06	6.76e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP19A1—esophageal cancer	5.22e-06	6.75e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GAPDH—esophageal cancer	5.11e-06	6.61e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CRABP1—esophageal cancer	5.07e-06	6.55e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	4.92e-06	6.36e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GNG7—esophageal cancer	4.82e-06	6.23e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—HMOX1—esophageal cancer	4.77e-06	6.16e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ALDH2—esophageal cancer	4.52e-06	5.83e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—HMOX1—esophageal cancer	4.49e-06	5.8e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ABCB1—esophageal cancer	4.31e-06	5.57e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTT1—esophageal cancer	4.29e-06	5.55e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	4.25e-06	5.49e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ENO1—esophageal cancer	4.02e-06	5.2e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.02e-06	5.2e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PSME2—esophageal cancer	3.97e-06	5.12e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PSME1—esophageal cancer	3.97e-06	5.12e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	3.42e-06	4.42e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.22e-06	4.16e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CREBBP—esophageal cancer	3.06e-06	3.95e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—HMOX1—esophageal cancer	2.94e-06	3.79e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CREBBP—esophageal cancer	2.88e-06	3.72e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ABCB1—esophageal cancer	2.82e-06	3.64e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NOS3—esophageal cancer	2.74e-06	3.54e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NOS3—esophageal cancer	2.58e-06	3.33e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PTGS2—esophageal cancer	2.5e-06	3.23e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PTGS2—esophageal cancer	2.36e-06	3.05e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—EP300—esophageal cancer	2.08e-06	2.69e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—EP300—esophageal cancer	1.96e-06	2.54e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.88e-06	2.43e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NOS3—esophageal cancer	1.69e-06	2.18e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.54e-06	1.99e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CA—esophageal cancer	1.54e-06	1.99e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	1.45e-06	1.88e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—EP300—esophageal cancer	1.28e-06	1.66e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	9.49e-07	1.23e-05	CbGpPWpGaD
